Actinogen Medical Limited Stock Performance
| ATGGF Stock | USD 0.04 0.00 0.00% |
On a scale of 0 to 100, Actinogen Medical holds a performance score of 9. The firm shows a Beta (market volatility) of -3.23, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Actinogen Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Actinogen Medical is expected to outperform it. Please check Actinogen Medical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Actinogen Medical's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Actinogen Medical Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Actinogen Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 13.4 M | |
| Total Cashflows From Investing Activities | -2937.00 |
Actinogen |
Actinogen Medical Relative Risk vs. Return Landscape
If you would invest 2.50 in Actinogen Medical Limited on September 28, 2025 and sell it today you would earn a total of 1.50 from holding Actinogen Medical Limited or generate 60.0% return on investment over 90 days. Actinogen Medical Limited is currently producing 0.9231% returns and takes up 7.4421% volatility of returns over 90 trading days. Put another way, 66% of traded pink sheets are less volatile than Actinogen, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Actinogen Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Actinogen Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Actinogen Medical Limited, and traders can use it to determine the average amount a Actinogen Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATGGF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Actinogen Medical is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Actinogen Medical by adding it to a well-diversified portfolio.
Actinogen Medical Fundamentals Growth
Actinogen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Actinogen Medical, and Actinogen Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Actinogen Pink Sheet performance.
| Return On Equity | -0.48 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (2.61) % | |||
| Operating Margin | (2.62) % | |||
| Current Valuation | 125.91 M | |||
| Shares Outstanding | 1.81 B | |||
| Price To Book | 12.26 X | |||
| Price To Sales | 49.62 X | |||
| Revenue | 3.64 M | |||
| EBITDA | (9.08 M) | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.52 M) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 23.31 M | |||
About Actinogen Medical Performance
By analyzing Actinogen Medical's fundamental ratios, stakeholders can gain valuable insights into Actinogen Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Actinogen Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Actinogen Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological, psychiatric, and metabolic diseases in Australia. Actinogen Medical Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Actinogen Med operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about Actinogen Medical performance evaluation
Checking the ongoing alerts about Actinogen Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Actinogen Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Actinogen Medical is way too risky over 90 days horizon | |
| Actinogen Medical has some characteristics of a very speculative penny stock | |
| Actinogen Medical appears to be risky and price may revert if volatility continues | |
| Actinogen Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.64 M. Net Loss for the year was (9.5 M) with profit before overhead, payroll, taxes, and interest of 3.64 M. | |
| Actinogen Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
- Analyzing Actinogen Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Actinogen Medical's stock is overvalued or undervalued compared to its peers.
- Examining Actinogen Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Actinogen Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Actinogen Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Actinogen Medical's pink sheet. These opinions can provide insight into Actinogen Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Actinogen Pink Sheet analysis
When running Actinogen Medical's price analysis, check to measure Actinogen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinogen Medical is operating at the current time. Most of Actinogen Medical's value examination focuses on studying past and present price action to predict the probability of Actinogen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinogen Medical's price. Additionally, you may evaluate how the addition of Actinogen Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |